Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1 (original) (raw)
Small-Molecule Phosphodiesterase Probes: Discovery of Potent and Selective CNS-Penetrable Quinazoline Inhibitors of PDE1
Jenna Head, Frank Menniti
MedChemComm, 2014
View PDFchevron_right
Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors
Julio Alvarez-Builla
Bioorganic & Medicinal Chemistry, 2013
View PDFchevron_right
Quinazolines: Combined type 3 and 4 phosphodiesterase inhibitors
Reto Naef
Bioorganic & Medicinal Chemistry Letters, 1998
View PDFchevron_right
Discovery of a new series of [1,2,4]triazolo[4,3-a]quinoxalines as dual phosphodiesterase 2/phosphodiesterase 10 (PDE2/PDE10) inhibitors
Andres Trabanco
Bioorganic & Medicinal Chemistry Letters, 2013
View PDFchevron_right
A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases
Yashi Agarwal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017
View PDFchevron_right
Identifying the structural features of pyrazolo[4,3-c]quinoline-3-ones as inhibitors of phosphodiesterase 4: An exploratory CoMFA and CoMSIA study
Current Enzyme Inhibition
View PDFchevron_right
Advances in targeting cyclic nucleotide phosphodiesterases
Vincent Manganiello
Nature Reviews Drug Discovery, 2014
View PDFchevron_right
Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors
Christoffer Bundgaard
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogs of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline
Robert Alvarez
Journal of Medicinal Chemistry, 1988
View PDFchevron_right
Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia † † Coordinates of the PDE10A crystal structures have been deposited in...
Frank Menniti
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
Synthesis and SAR study of new phenylimidazole-pyrazolo[1,5-c]quinazolines as potent phosphodiesterase 10A inhibitors
Battistina Asproni, Gabriele Murineddu
Bioorganic & Medicinal Chemistry, 2011
View PDFchevron_right
Insight into Binding of Phosphodiesterase-9A Selective Inhibitors by Crystal Structures and Mutagenesis
Hengming Ke
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design
Hengming Ke
Journal of Medicinal Chemistry, 2012
View PDFchevron_right
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
Prabha Ibrahim
Structure, 2004
View PDFchevron_right
Kinetic and Structural Studies of Phosphodiesterase-8A and Implication on the Inhibitor Selectivity † ‡
Howard Robinson
Biochemistry, 2008
View PDFchevron_right
Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration
Margarete Neu, Stuart Ballantine, Chris Delves
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Design, synthesis and evaluation of N2,N4-diaminoquinazoline based inhibitors of phosphodiesterase type 5
Nattakarn Pobsuk
Bioorganic & Medicinal Chemistry Letters, 2018
View PDFchevron_right
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design
Prabha Ibrahim
Nature Biotechnology, 2005
View PDFchevron_right
CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors
maulik patel
Bioorganic & Medicinal Chemistry, 2008
View PDFchevron_right
Classification of Phosphodiesterases and the Therapeutic Effects of their Inhibitors (Review
IJSES Editor
View PDFchevron_right
Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)
Ji Ma
Journal of medicinal chemistry, 2014
View PDFchevron_right
Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors
ana castro
Medicinal Research Reviews, 2005
View PDFchevron_right
cAMP-dependent phosphodiesterase inhibition and SAR studies on novel 6,8-disubstituted 2-phenyl-3-(substituted benzothiazole-2-yl)-4[3H]-quinazolinone
Dr Sachin S Laddha
Medicinal Chemistry Research, 2009
View PDFchevron_right